126 related articles for article (PubMed ID: 15325130)
1. Manipulation of PrPres production in scrapie-infected neuroblastoma cells.
Bate C; Langeveld J; Williams A
J Neurosci Methods; 2004 Sep; 138(1-2):217-23. PubMed ID: 15325130
[TBL] [Abstract][Full Text] [Related]
2. Cytochalasin D enhances the accumulation of a protease-resistant form of prion protein in ScN2a cells: involvement of PI3 kinase/Akt signalling pathway.
Takenouchi T; Iwamaru Y; Imamura M; Fukuhara S; Sugama S; Sato M; Mochizuki N; Hashimoto M; Yokoyama T; Mohri S; Kitani H
Cell Biol Int; 2012; 36(12):1223-31. PubMed ID: 22985412
[TBL] [Abstract][Full Text] [Related]
3. Increased levels of insulin and insulin-like growth factor-1 hybrid receptors and decreased glycosylation of the insulin receptor alpha- and beta-subunits in scrapie-infected neuroblastoma N2a cells.
Nielsen D; Gyllberg H; Ostlund P; Bergman T; Bedecs K
Biochem J; 2004 Jun; 380(Pt 2):571-9. PubMed ID: 15025560
[TBL] [Abstract][Full Text] [Related]
4. Protease-resistant prion protein in brain and lymphoid organs of sheep within a naturally scrapie-infected flock.
Madec JY; Groschup MH; Calavas D; Junghans F; Baron T
Microb Pathog; 2000 Jun; 28(6):353-62. PubMed ID: 10839972
[TBL] [Abstract][Full Text] [Related]
5. Valproic acid treatment results in increased accumulation of prion proteins.
Shaked GM; Engelstein R; Avraham I; Rosenmann H; Gabizon R
Ann Neurol; 2002 Oct; 52(4):416-20. PubMed ID: 12325069
[TBL] [Abstract][Full Text] [Related]
6. Microglia Are Critical in Host Defense against Prion Disease.
Carroll JA; Race B; Williams K; Striebel J; Chesebro B
J Virol; 2018 Aug; 92(15):. PubMed ID: 29769333
[TBL] [Abstract][Full Text] [Related]
7. Calpain-dependent endoproteolytic cleavage of PrPSc modulates scrapie prion propagation.
Yadavalli R; Guttmann RP; Seward T; Centers AP; Williamson RA; Telling GC
J Biol Chem; 2004 May; 279(21):21948-56. PubMed ID: 15026410
[TBL] [Abstract][Full Text] [Related]
8. Nonpsychoactive cannabidiol prevents prion accumulation and protects neurons against prion toxicity.
Dirikoc S; Priola SA; Marella M; Zsürger N; Chabry J
J Neurosci; 2007 Sep; 27(36):9537-44. PubMed ID: 17804615
[TBL] [Abstract][Full Text] [Related]
9. In vitro evaluation of the anti-prionic activity of newly synthesized congo red derivatives.
Poli G; Ponti W; Carcassola G; Ceciliani F; Colombo L; Dall'Ara P; Gervasoni M; Giannino ML; Martino PA; Pollera C; Villa S; Salmona M
Arzneimittelforschung; 2003; 53(12):875-88. PubMed ID: 14750496
[TBL] [Abstract][Full Text] [Related]
10. Squalestatin cures prion-infected neurons and protects against prion neurotoxicity.
Bate C; Salmona M; Diomede L; Williams A
J Biol Chem; 2004 Apr; 279(15):14983-90. PubMed ID: 14754889
[TBL] [Abstract][Full Text] [Related]
11. Epitope scanning reveals gain and loss of strain specific antibody binding epitopes associated with the conversion of normal cellular prion to scrapie prion.
Pan T; Li R; Kang SC; Wong BS; Wisniewski T; Sy MS
J Neurochem; 2004 Sep; 90(5):1205-17. PubMed ID: 15312175
[TBL] [Abstract][Full Text] [Related]
12. Kinetics of expression of prion protein in uninfected and scrapie-infected N2a mouse neuroblastoma cells.
Pfeifer K; Bachmann M; Schröder HC; Forrest J; Müller WE
Cell Biochem Funct; 1993 Mar; 11(1):1-11. PubMed ID: 8095862
[TBL] [Abstract][Full Text] [Related]
13. Changed iron regulation in scrapie-infected neuroblastoma cells.
Fernaeus S; Hälldin J; Bedecs K; Land T
Brain Res Mol Brain Res; 2005 Feb; 133(2):266-73. PubMed ID: 15710243
[TBL] [Abstract][Full Text] [Related]
14. Antiprion activity of cholesterol esterification modulators: a comparative study using ex vivo sheep fibroblasts and lymphocytes and mouse neuroblastoma cell lines.
Pani A; Norfo C; Abete C; Mulas C; Putzolu M; Laconi S; Orrù CD; Cannas MD; Vascellari S; La Colla P; Dessì S
Antimicrob Agents Chemother; 2007 Nov; 51(11):4141-7. PubMed ID: 17709472
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of quinacrine treatment for prion diseases.
Barret A; Tagliavini F; Forloni G; Bate C; Salmona M; Colombo L; De Luigi A; Limido L; Suardi S; Rossi G; Auvré F; Adjou KT; Salès N; Williams A; Lasmézas C; Deslys JP
J Virol; 2003 Aug; 77(15):8462-9. PubMed ID: 12857915
[TBL] [Abstract][Full Text] [Related]
16. Opposite effects of dextran sulfate 500, the polyene antibiotic MS-8209, and Congo red on accumulation of the protease-resistant isoform of PrP in the spleens of mice inoculated intraperitoneally with the scrapie agent.
Beringue V; Adjou KT; Lamoury F; Maignien T; Deslys JP; Race R; Dormont D
J Virol; 2000 Jun; 74(12):5432-40. PubMed ID: 10823847
[TBL] [Abstract][Full Text] [Related]
17. Immunolocalisation of PrPSc in scrapie-infected N2a mouse neuroblastoma cells by light and electron microscopy.
Veith NM; Plattner H; Stuermer CA; Schulz-Schaeffer WJ; Bürkle A
Eur J Cell Biol; 2009 Jan; 88(1):45-63. PubMed ID: 18834644
[TBL] [Abstract][Full Text] [Related]
18. Anchorless prion protein results in infectious amyloid disease without clinical scrapie.
Chesebro B; Trifilo M; Race R; Meade-White K; Teng C; LaCasse R; Raymond L; Favara C; Baron G; Priola S; Caughey B; Masliah E; Oldstone M
Science; 2005 Jun; 308(5727):1435-9. PubMed ID: 15933194
[TBL] [Abstract][Full Text] [Related]
19. Phosphorothioate oligonucleotides reduce PrP levels and prion infectivity in cultured cells.
Karpuj MV; Giles K; Gelibter-Niv S; Scott MR; Lingappa VR; Szoka FC; Peretz D; Denetclaw W; Prusiner SB
Mol Med; 2007; 13(3-4):190-8. PubMed ID: 17592554
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and trafficking of prion proteins in cultured cells.
Taraboulos A; Raeber AJ; Borchelt DR; Serban D; Prusiner SB
Mol Biol Cell; 1992 Aug; 3(8):851-63. PubMed ID: 1356522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
